test embed

Disclaimer: The TIF procedure may not be appropriate for your condition and results may vary. Talk to your doctor about benefits and risks. This message is co-funded by EndoGastric Solutions.

Important: While clinical studies support the effectiveness of TIF (Transoral Incisionless Fundoplication) in treating chronic GERD (gastroesophageal reflux disease), individual results may vary. There are no guarantees of successful outcome. The TIF surgery may not be appropriate for every individual, and it may not be applicable to your condition. The individual opinions of previous TIF surgery patients presented on this page do not reflect the opinions of EndoGastric Solutions, Inc., and should not be considered as medical advice. Always ask your doctor about all treatment options, as well as their risks and benefits. Only your doctor can determine whether the TIF surgery is appropriate for your situation.

Safety Information and Warnings: While the TIF procedure is less invasive than conventional laparoscopic fundoplication and has an excellent safety profile, it is important to note that TIF is still a surgical procedure. All surgical procedures have risks. Therefore, it is important to understand the associated risks. Before you decide on a procedure, speak to your surgeon in detail about the risks and complications that may arise. Expected risks or discomforts anticipated as a result of an endoscopic procedure include: Pharyngolaryngeal pain (sore throat), Musculoskeletal pain (left shoulder pain), Temporary epigastric or abdominal pain which can be treated with standard pain medication, Temporary dysphagia (difficulty swallowing) due to swelling, Nausea or vomiting. These expected events occur in greater than 25% or more than 25 out of 100 people who have the TIF procedure. They are usually mild in severity and resolve themselves shortly after surgery. For Full Safety Information Click HERE.

Indications – If you are an adult (at least 18 years old). If you have symptomatic chronic gastroesophageal reflux disease (GERD). If you require and respond to pharmacological therapy. If you have a hiatal hernia less than or equal to 2cm in size. If you have a Body Mass Index (BMI) less than 35. If your surgeon may have other criteria he or she uses to determine whether If you are an appropriate candidate. Ask If your surgeon to discuss those criteria with If you.

Contraindications – If you have a bleeding disorder, chronic cough, stricture, severe esophagitis, esophageal diverticulae, an obstruction, a paraesophageal hernia, limited neck mobility, osteophytes of the spine, esophageal varices, esophageal infections or fungal disease, or esophageal stenosis. If you have any kind of normal or abnormal esophageal anatomy which would prohibit insertion of the EsophyX device.
If you cannot adhere to the post-operative diet recommended for appropriate healing. If you are under 18 years old. If you have a hiatal hernia greater than 2cm in size. If you have a BMI greater than 35. If you are pregnant.

References:
[1] Barnes, W.E., et al. Transoral incisionless esophago-gastric fundoplication offers high patient satisfaction and relief of therapy-resistant typical and atypical symptoms of GERD in community practice. Surgical Innovation (published Fedruary 8, 2011).
[2] Bell, R.C.W., Freeman K. Clinical and pH-metric outcomes of transoral esophago-gastric fundoplication for the treatment of gastroesophageal reflux disease (GERD). Surgical Endoscopy (published online on December 13, 2010).
[3] Cadière, GB, et al. Antireflux transoral incisionless fundoplication using EsophyX™: 12-month results of a prospective multicenter study. World Journal of Surgery 2008; 32: 1676-1688.
[4] Cadièr,e GB, et al. Two-year results of a feasibility study on antireflux transoral incisionless fundoplication (TIF) using EsophyX. Surgical Endoscopy 2009; 23: 957-964.
[5] Velanovich, V. Endoscopic, endoluminal fundoplication for gastroesophageal reflux disease: initial experience and lessons learned. Surgery 2010; 148:646-53.
[6] FDA – Possible Increased Risk of Bone Fractures With Certain Antacid Drugs http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm213240.htm

[7]Incisionless Endoscopic Procedure Significantly More Effective at Eliminating Chronic GERD Symptoms than Maximum PPI Dose, New Data Show-
https://www.endogastricsolutions.com/2013/05/incisionless-endoscopic-procedure-significantly-more-effective-at-eliminating-chronic-gerd-symptoms-than-maximum-ppi-dose-new-data-show/

[8]Transoral fundoplication offers durable symptom control for chronic GERD: 3-year report from the TEMPO randomized trial with a crossover arm
-https://www.gerdhelp.com/blog/references/transoral-fundoplication-offers-durable-symptom-control-for-chronic-gerd-3-year-report-from-the-tempo-randomized-trial-with-a-crossover-arm/

All rights reserved. EndoGastric, EsophyX, SerosaFuse and TIF names and logos, are registered trademarks of EndoGastric Solutions.
All other product names and logos are trademarks or registered trademarks of their respective holders. 2021 – West Adaptive